Showing results (831-840 of 4,513) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|August 17, 2012
The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinomaIlaria Imarisio, Chiara Paglino, Carlo Ganini, et al.
Future Oncology (London, England)|May 2, 2023
Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic reviewCharlotte L Moss, Teresa Guerrero-Urbano, Ingrid White, et al.
Future Oncology (London, England)|May 2, 2023
Noninvasive detection of soft tissue sarcoma using volatile organic compounds in exhaled breath: a pilot studyIbtissam Acem, Veroniek M van Praag, Cassidy Qb Mostert, et al.
Future Oncology (London, England)|May 2, 2023
Young age is associated with inferior outcomes in early-stage luminal B breast cancer patients who undergo mastectomyJianjing Hou, Lun Li, Jia Wang, et al.
Future Oncology (London, England)|May 10, 2023
Defining ruxolitinib failure and transition to next-line therapy for patients with myelofibrosis: a modified Delphi panel consensus studyJohn Mascarenhas, Hiep Nguyen, Ashley Saunders, et al.
Future Oncology (London, England)|May 12, 2023
Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology ClinicsRichard W DeClue, Elizabeth A Szamreta, Santosh Gautam, et al.
Future Oncology (London, England)|January 29, 2015
Common EGFR-mutated subgroups (Del19/L858R) in advanced non-small-cell lung cancer: chasing better outcomes with tyrosine kinase inhibitorsNoemi Reguart, Jordi Remon
Future Oncology (London, England)|July 27, 2012
Should human papillomavirus DNA testing be offered in combination with cytology or as a sole primary screening test in cervical cancer prevention?Amanda Tristram
Future Oncology (London, England)|July 27, 2012
Ten challenges in the management of neuroblastomaJennifer Gains, Henry Mandeville, Nicholas Cork, et al.
Future Oncology (London, England)|July 27, 2012
PARP cleavage and perturbance in mitochondrial membrane potential by 3-α-propionyloxy-β-boswellic acid results in cancer cell death and tumor regression in murine modelsYasrib Qurishi, Abid Hamid, Parduman R Sharma, et al.
Pageof 452